Huma obtains multi-condition Saudi FDA Class C regulatory certification for its configurable SaMD disease management platform
The Kingdom's ambitious and groundbreaking healthcare program now has a software supplier that can support its vision and growth.
- The Kingdom's ambitious and groundbreaking healthcare program now has a software supplier that can support its vision and growth.
- Huma's SaMD platform powers digital health pathways through which data are collected from patients for self-management or to be assessed centrally by clinicians.
- With the recent attainment of Saudi FDA Class C certification, complementing its existing Class IIb regulatory certification in the EU and Class II 510(k) in the USA, the SaMD platform reaches a new pinnacle in patient care versatility.
- Our Class C-approved platform offers a customizable solution, significantly reducing risk and making digital health innovation more accessible and democratic."